1315 (1315) Fair Value & Analysis

Basic Materials · Market cap HK$60.9M

1 1315 1315 · HK

PriceHK$0.1010

Fair ValueHK$0.5200

Upside+414.9%

Quality40/100

Evidence: Low Range HK$0.3900 – HK$0.6500

Fair value as of: Jul 2, 2026

From 24 valuation models · updated today

Share price −9.0% over the past month.

Price vs Fair Value (12 months)

12‑month range HK$0.0950 – HK$0.2370 · fair‑value band HK$0.3900 – HK$0.6500 · the HK$0.1010 price screens below the HK$0.5200 fair value. As of Jul 2, 2026.

✦ Which stocks are undervalued right now? Check free Discover now →

Analysis

1315 (1315) currently trades at HK$0.1010, while our model-based Fair Value estimate is HK$0.5200 — implying the stock looks roughly 414.9% undervalued today. We read business quality at 40/100 (below-average quality), in the Basic Materials sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: low) — always confirm before acting.

Over the trailing twelve months, 1315 generated revenue of HK$2.8B at a net margin of 0.6%. Revenue grew 0.9% year over year. It earns a return on equity of 18.4%. Net debt stands at HK$63.2M. Fundamentals as of Jul 2, 2026

Key figures & financial health

Revenue (TTM) HK$2.8B

Revenue growth (YoY) +0.9%

Net margin 0.6%

Return on equity 18.4%

Free cash flow HK$57.9M FY2025

P/E ratio 2.5

More key figures

Operating margin -0.7%

EPS (TTM) HK$0.0400

EPS growth (YoY) +82.5%

Net debt HK$63.2M FY2025

Figures from reported company fundamentals (EODHD) · as of Jul 2, 2026. TTM = trailing twelve months.

Revenue & earnings trend

FY2021 – FY2025 · reported fiscal years

1315 reported revenue of HK$2.8B in FY2025 versus HK$5.2B in FY2021, a compound −14.2%/yr. Reported net income was HK$15.4M in FY2025, compounding +20.9%/yr from FY2021.

Revenue −14.2%/yr

FY21 HK$5.2B

FY22 HK$4.0B

FY23 HK$2.5B

FY24 HK$2.9B

FY25 HK$2.8B

Net income +20.9%/yr

FY21 HK$7.2M

FY22 −HK$13.6M

FY23 −HK$85.3M

FY24 HK$18.2M

FY25 HK$15.4M

Is 1315 fairly valued? → Check now

Similar stocks

6 more Building Materials stocks, each showing price versus our Fair Value estimate (as of Jul 2, 2026).

Stock	Price	Fair Value	vs Fair Value
CRH plc CRH	$111.25	$70.25	-37%
Holcim AG HCMLY	$19.20	$8.68	-55%
Heidelberg Materials AG HEI	€172.00	€136.22	-21%
Vulcan Materials Company VMC	$304.39	$119.01	-61%
Martin Marietta Materials, Inc MLM	$552.87	$149.37	-73%
UltraTech Cement Limited ULTRACEMCO	₹10,912	₹4,589	-58%

Explore undervalued stocks

More undervalued Basic Materials stocks →

All undervalued stocks Technology Financial Services Healthcare Consumer Cyclical Consumer Defensive Communication Services Industrials Energy Basic Materials Real Estate Utilities Deeply Undervalued Stocks Undervalued Blue-Chip Stocks Undervalued Small-Cap Stocks

Frequently asked questions

Is 1315 (1315) undervalued?

As of Jul 2, 2026, our model estimates a fair value of HK$0.5200 versus a price of HK$0.1010 — about +415% (undervalued). Model-based estimate, not financial advice.

What is the fair value of 1315?

Our model-based fair value for 1315 is HK$0.5200 (as of Jul 2, 2026), built from audited fundamentals. The current price is HK$0.1010.

What is the quality score of 1315?

1315 has a Quality Score of 40/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

What is the revenue of 1315 (1315)?

1315 reported trailing-twelve-month revenue of about HK$2.8B (latest available figure, as of Jul 2, 2026).

What is the net profit margin of 1315?

The net profit margin of 1315 is about 0.6%, meaning it keeps roughly 0.6% of revenue as net income. Based on the latest reported figures.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.